AdvanCell’s Generator is a world-first alpha isotope generator which addresses the greatest unmet need in targeted alpha therapy – the reliable and scalable supply of isotope. The manufacture of clinical doses of a high-value isotope Alpha 212® (Lead-212) for use in targeted radionuclides therapy is a game-changer for prostate and several other cancer treatments. Enabling scalable local isotope production capability, the Generator will fast track the delivery of cutting-edge cancer treatments to patients.
Femom captures essential maternal-fetal bio-signals remotely, and enables clinicians to review it to assess health of the mother and baby. Using electrocardiogram (ECG), the Femom fetal monitor is designed as clinical-grade device, allowing greater access to care and data on the development of the fetus and maternal health. The high-resolution data can be used to identify risks before they become emergencies, and ensure a safer and smoother maternity journey. [Research Use Only]